The Accreditation Committee of the College of American Pathologists (CAP) awarded accreditation to IBX, Piscataway, New Jersey Laboratory, based on results of a recent on-site inspection as part of the CAP’s Accreditation Programs.
Chief Scientific Officer, Shareef Nahas, PHD, was advised of this national recognition and congratulated for the excellence of the services being provided. IBX is one of more than 8,000 CAP-accredited facilities worldwide.
“With CAP inspections every three years, renewing this accreditation is always an important milestone for IBX and we’re incredibly proud to receive this news. It represents the ongoing efforts of our team and how well placed we are to support our clients with the breadth of experience we have in biobanking and the management of biospecimens,” said Nahas.
Robin Grimwood, CEO at IBX, said: “Maintaining high quality and standards as we more than double the size of our biorepository is essential for our clients and their samples. We know biospecimens are integral to improving patient outcomes and demand for biobanking services to support precision medicine is greater than ever. At IBX we see the standards set by CAP, which draws on best practices from ISBER, NCI, OECD, CMS, as vital to our mission to be the lab behind every transformative health innovation.”